Translational Development Acquisition Corp. (TDAC) Max Pain Analysis

Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.

Translational Development Acquisition Corp. (TDAC) operates in the Financial Services sector, specifically the Shell Companies industry, with a market capitalization near $233.1M, listed on NASDAQ, employing roughly 2 people, carrying a beta of -0.00 to the broader market. Translational Development Acquisition Corp. Led by Michael Hoffman, public since 2025-02-20.

Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for TDAC as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how max pain is reported and how to read the data →